Top Biotechnology companies in United States by EBIT

This ranking features the top 509 Biotechnology companies in United States ranked by EBIT, totaling a EBIT of USD 69.90 B, for June 27, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue EBITDA Net Income Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

1 2 3 4 … 11

Frequently Asked Questions

Which Biotechnology company in United States has the highest EBIT ?

The Biotechnology company in United States with the highest EBIT is Merck & Co., Inc. (NYSE: MRK) at USD 22.70 B.
Which Biotechnology company in United States has the lowest EBIT ?

The Biotechnology company in United States with the lowest EBIT is Amylyx Pharmaceuticals, Inc. (NasdaqGS: AMLX) at None.

What are the top 10 Biotechnology companies in United States by EBIT ?

The top 10 Biotechnology companies in United States by EBIT are Merck & Co., Inc., Pfizer Inc., Amgen Inc., Bristol-Myers Squibb Company, Abbott Laboratories, AbbVie Inc., Thermo Fisher Scientific Inc., Gilead Sciences, Inc., Danaher Corporation and Regeneron Pharmaceuticals, Inc..
What are the bottom 10 Biotechnology companies in United States by EBIT ?

The bottom 10 Biotechnology companies in United States by EBIT are Amylyx Pharmaceuticals, Inc., Anika Therapeutics, Inc., Autonomix Medical, Inc. Common Stock, Aldeyra Therapeutics, Inc., Allogene Therapeutics, Inc., ABVC BioPharma, Inc., Adagio Medical Holdings, Inc., Adverum Biotechnologies, Inc., Aditxt, Inc. and Anixa Biosciences, Inc..